世界の製薬産業における事業提携、ライセンス、投資、M&A動向(2014年第4四半期版)...市場調査レポートについてご紹介

【英文タイトル】Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 11
2 Pharmaceuticals & Healthcare, Global, Deal Summary, Q4 2014 15
2.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, Q4 2014 15
2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, Q4 2014 17
2.3 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, Q4 2014 18
2.4 Pharmaceuticals & Healthcare, Global, Top Deals, Q4 2014 19
2.4.1 Actavis to Acquire Allergan for USD66 Billion 19
2.4.2 Medtronic Raises USD17 Billion in Private Placement of Notes 20
2.4.3 Merck Acquires Cubist Pharma for USD9.5 Billion 20
2.4.4 Bayer Raises USD7 Billion in Public Offering Bonds 21
2.4.5 LabCorp to Acquire Covance for USD6.1 Billion 21
3 Pharmaceuticals & Healthcare, Global, Deals Summary, by Type 23
3.1 Pharmaceuticals & Healthcare, Global, M&A, Q4 2014 23
3.1.1 Top M&A Deals in Q4 2014 24
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, Q4 2013 – Q4 2014 25
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Q4 2014 26
3.2.1 Top Initial Public Offerings in Q4 2014 27
3.2.2 Top Secondary Offerings in Q4 2014 28
3.2.3 Top PIPE Deals in Q4 2014 28
3.2.4 Pharmaceuticals & Healthcare, Global, Top IPOs Share Performance, Q4 2013-Q4 2014 29
3.2.5 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Q4 2013 – Q4 2014 29
3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, Q4 2014 31
3.3.1 Top Venture Financing Deals in Q4 2014 32
3.3.2 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q4 2014 33
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q4 2014 34
3.3.4 Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, Q4 2013 – Q4 2014 35
3.3.5 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Q4 2013 – Q4 2014 36
3.3.6 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Q4 2013 – Q4 2014 37
3.4 Pharmaceuticals & Healthcare, Global, Private Equity Deals, Q4 2014 38
3.4.1 Top Private Equity Deals in Q4 2014 39
3.4.2 Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Q4 2013 – Q4 2014 40
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q4 2014 42
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q4 2014 42
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Q4 2013 – Q4 2014 44
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Values (US$ m), Q4 2014 46
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Deal Values, Q4 2014 47
4.3.2 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, Q4 2014 48
4.3.3 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payments, Q4 2014 48
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), Q4 2013 – Q4 2014 49
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, Q4 2013 – Q4 2014 51
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), Q4 2013 – Q4 2014 52
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), Q4 2013 – Q4 2014 53
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, Q4 2014 55
5.1 Pharmaceutical & Healthcare, Global, Licensing Agreements, Q4 2014 55
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q4 2013 – Q4 2014 57
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Deal Value, Q4 2014 58
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, Q4 2014 59
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Milestone Payment, Q4 2014 60
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Total Deal Value (US$ m), Q4 2013 – Q4 2014 61
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Upfront Payments Vs Milestone Payments (US$ m), Q4 2013 – Q4 2014 63
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q4 2013 – Q4 2014 65
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q4 2013 – Q4 2014 66
5.7 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Upfront Payments Vs Milestone Payments (US$ m), Q4 2013 – Q4 2014 68
6 Pharmaceuticals & Healthcare, Global, M&A Financial Analysis 70
6.1 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value versus Median Deal Value, Q4 2013 – Q4 2014 70
6.2 Pharmaceuticals& Healthcare, Global Acquisitions, Average Price Earnings of Acquired Companies, Q4 2013 – Q4 2014 72
6.3 Pharmaceuticals & Healthcare, Global Acquisitions, Average EV/EBITDA of Acquired Companies, Q4 2013 – Q4 2014 73
6.4 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value per Operating Profit, Q4 2013 – Q4 2014 75
6.5 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Market Price Per Share, Q4 2013 – Q4 2014 77
6.6 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Book Value Per Share, Q4 2013 – Q4 2014 78
6.7 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Sales, Q4 2013 – Q4 2014 79
7 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 80
7.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, Q4 2014 80
7.1.1 Oncology – Deals of the Quarter 82
7.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, Q4 2014 84
7.2.1 Central Nervous System – Deals of the Quarter 86
7.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, Q4 2014 88
7.3.1 Infectious Disease – Deals of the Quarter 89
7.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, Q4 2014 92
7.4.1 Immunology – Deals of the Quarter 94
7.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, Q4 2014 96
7.5.1 Metabolic Disorders – Deals of the Quarter 97
7.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, Q4 2014 100
7.6.1 Cardiovascular – Deals of the Quarter 101
7.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, Q4 2014 103
7.7.1 Gastrointestinal – Deals of the Quarter 104
7.8 Pharmaceuticals & Healthcare, Global, Dermatology Deals, Q4 2014 106
7.8.1 Dermatology – Deals of the Quarter 107
7.9 Pharmaceuticals & Healthcare, Global, Respiratory Deals, Q4 2014 109
7.9.1 Respiratory – Deals of the Quarter 110
7.10 Pharmaceuticals & Healthcare, Global, Ophthalmology Deals, Q4 2014 113
7.10.1 Ophthalmology – Deals of the Quarter 114
8 Deal Summary by Geography 117
8.1 Pharmaceuticals & Healthcare, North America Region, Deals, Q4 2014 117
8.1.1 North America – Deals of the Quarter 119
8.2 Pharmaceuticals & Healthcare, Europe Region, Deals, Q4 2014 121
8.2.1 Europe – Deals of the Quarter 122
8.3 Pharmaceuticals & Healthcare, Asia-Pacific, Deals, Q4 2014 126
8.3.1 Asia-Pacific – Deals of the Quarter 127
8.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, Q4 2014 129
8.4.1 Rest of the World – Deals of the Quarter 130
9 Pharmaceuticals & Healthcare, Global, Top Advisors 132
9.1 Pharmaceuticals & Healthcare, Global Top Financial Advisors, M&A, Q4 2013 – Q4 2014 132
9.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Q4 2013 – Q4 2014 134
10 Appendix 136
11 Further Information 139
11.1 Methodology 139
11.2 About GlobalData 140
11.3 Disclosure information 141
11.4 Disclaimer 141


【レポート販売概要】

■ タイトル:世界の製薬産業における事業提携、ライセンス、投資、M&A動向(2014年第4四半期版)
■ 英文:Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2014
■ 発行日:2015年2月15日
■ 調査会社:GlobalData
■ 商品コード:GDPH0473QD
■ 調査対象地域:グローバル
  • 女性衛生用品の世界市場:生理用ナプキン、おりものシート、タンポン
    About feminine hygiene Feminine hygiene products are used by women during their menstrual cycle or during vulva discharge. These products are available in both disposable and washable forms. Technavio's analysts forecast the global feminine hygiene market to grow at a CAGR 4.92% in terms of revenue during 2014-2019. [Covered in this report] The global feminine hygiene market can be segmented into …
  • モバイル端末向けハプティック技術の世界市場
    About haptic technology Haptics or haptic technology is a tactile feedback technology that uses the sense of touch by applying forces and vibrations motions to a user. Through this technology, end-users are able to perceive touch sensations when using electronic devices. Haptics are enabled by actuators that are embedded in a device, and it makes the user experience more physical and realistic. Ha …
  • コンバージドインフラストラクチャーの世界市場2019-2023
    About this market The simplified management is one of the critical reasons that will drive the converged infrastructure market. The management of converged infrastructure stack is very simple in comparison to a traditional three-tier data center infrastructure. This is because the system management tools used in converged infrastructure provides a single point through which the entire infrastructu …
  • 防水層の世界市場:変性ビチューメン、PVC、EPDM、TPO、HDPE、LDPE
    The waterproofing membranes market is projected to reach USD 36.62 Billion by 2021, at a CAGR of 9.2%. The market is driven by the growing building & construction industry and increased use of waterproofing membranes in waste management and water treatment applications globally. However, the mature markets of Europe and North America are projected to inhibit the growth to some extent. Roofing & wa …
  • Cerebral Aneurysms:グローバル臨床試験レビューH1, 2013
    Cerebral Aneurysms Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Cerebral Aneurysms Global Clinical Trials Review, H1, 2013" provides data on the Cerebral Aneurysms clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cerebral Aneurysms. It includes an overview of the trial numbers and their recruitme …
  • スロットマシンの世界市場2017-2021
    About Slot MachinesSlot machines are casino gambling machines with three or more reels that spin when a button is pushed. Technavio’s analysts forecast the global slot machines market to grow at a CAGR of 15.49% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth prospects of the global slot machines market for 2017-2021. To calculate the mar …
  • OLED材料の世界市場
    ABSTRACTAbout OLED Materials OLED are made of organic (carbon-based) materials that emit light when the electricity is applied to them. OLEDs are used for lighting and displays. OLEDs are used in the mass production of active matrix organic light-emitting diode (AMOLED) panels, including the red, green, and blue (RGB) light-emitting materials. The materials of the common layers include hole transp …
  • 医療用チューブの世界市場予測(~2021年):PVC、ポリオレフィン、TPE、TPU、シリコンチューブ
    The medical tubing market size is projected to witness a CAGR of 8.0% from 2016 to reach a market size of USD 5.85 Billion, by 2021. The market is mainly driven by minimally invasive surgery. Another major factor that is expected to bring momentum to this market are increasing aging population, especially in developing countries, and the rising awareness about healthcare and the government initiat …
  • バーチャル発電所の世界市場予測(~2021)
    The global virtual power plant market is projected to grow at a CAGR of 29.68% from 2016 to 2021, to reach a market size of USD 709.2 Million by 2021. This growth is attributed to the increasing penetration of smart grid technologies as well as increase in residential energy storage system has given rise to the virtual power plant market. An aggregated fleet of distributed energy resources would p …
  • POC脂質検査の世界市場2017-2021
    ABSTRACTAbout POC Lipid Testing Point-of-care (POC) lipid testing is used to measure the lipid level of the blood at a convenient place near the patient. The test also measures high-density lipoprotein (HDL), low-density lipoprotein (LDL), cholesterol, and triglyceride level of the blood. POC tests help reduce the time between the diagnosis and treatment of a disease. They are antibody-based or mi …
  • スマートキッチンの世界市場:スマート冷蔵庫、スマート調理機器、スマート食器洗い機
    About Smart Kitchen The Internet of Things (IoT) is a network of physical or tangible objects or devices interconnected through multiple network technologies. These objects or devices can communicate with each other and with the external environment through the Internet. Smart kitchens are an integral part of smart homes. Smart kitchens provide a smart environment, which makes it easy for the user …
  • ヘルスケア産業向けパッケージ(包装材料)の世界市場2015-2025
    We predict the global healthcare packaging market will reach a value of $101.3 billion in 2015 and will grow at a CAGR of 6.3% between 2015 and 2025. Strong growth in the healthcare sectors around the world and increasing functional requirements for healthcare packaging products are some of the key growth factors in the global healthcare packaging market. A global ageing population, changing lifes …
  • Pan Orient Energy Corp.:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013
    Pan Orient Energy Corp. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Pan Orient Energy Corp. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential so …
  • 複合ベアリングの世界市場展望2017-2026
    According to Stratistics MRC, the Global Composite Bearings market accounted for $ 3.80 billion in 2017 and is expected to reach $ 8.19 billion by 2026 growing at a CAGR of 8.9% during the forecast period. Some of the key factors such as increasing need of long product life with low maintenance cost, rapid technological advancements in production process, longer product life and providing superior …
  • 世界のスマート・ファクトリ市場:SCADA, DCS, PLC, ERP, MES, PLM, MOM
    The Smart Factory is referred to as a fully integrated and affordable factory automation solution that streamlines the flow of materials through a manufacturing facility. Most of the industry experts believe that the smart factory will be the next big fixation in the industrial revolution. It offers MES and factory specific templates, enables problem visibility, and delivers factory reports and da …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。